These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6307649)

  • 1. Monoiodoglucagon: synthesis, purification by high pressure liquid chromatography, and characteristics as a receptor probe.
    Rojas FJ; Swartz TL; Iyengar R; Garber AJ; Birnbaumer L
    Endocrinology; 1983 Aug; 113(2):711-9. PubMed ID: 6307649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, purification by HPLC and characterization of monoiodoglucagon labeled with carrier free 125I: use as glucagon receptor probe.
    Birnbaumer L; Swartz TL; Rojas FJ; Garber AJ
    J Recept Res; 1983; 3(1-2):3-20. PubMed ID: 6304305
    [No Abstract]   [Full Text] [Related]  

  • 3. The hepatic glucagon receptor: a comparative study of the regulatory and structural properties.
    Padrell E; Herberg JT; Monsatirsky B; Floyd G; Premont RT; Iyengar R
    Endocrinology; 1987 Jun; 120(6):2316-25. PubMed ID: 3032585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural analysis of the hepatic glucagon receptor. Identification of a guanine nucleotide-sensitive hormone-binding region.
    Iyengar R; Herberg JT
    J Biol Chem; 1984 Apr; 259(8):5222-9. PubMed ID: 6325424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the 10-13 region of glucagon for its receptor interactions and activation of adenylate cyclase.
    Krstenansky JL; Trivedi D; Hruby VJ
    Biochemistry; 1986 Jul; 25(13):3833-9. PubMed ID: 3017406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor binding and cell-mediated metabolism of [125I]monoiodoglucagon by isolated canine hepatocytes.
    Hagopian WA; Tager HS
    J Biol Chem; 1984 Jul; 259(14):8986-93. PubMed ID: 6086619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hepatic glucagon receptor. Solubilization, characterization, and development of an affinity adsorption assay for the soluble receptor.
    Herberg JT; Codina J; Rich KA; Rojas FJ; Iyengar R
    J Biol Chem; 1984 Jul; 259(14):9285-94. PubMed ID: 6086631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iodoglucagon. Preparation and characterization.
    Desbuquois B
    Eur J Biochem; 1975 May; 53(2):569-80. PubMed ID: 1140201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of oxidation of the Met27 residue of [125I]monoiodoglucagon on receptor-binding affinity.
    Sonne O; Larsen UD; Markussen J
    Hoppe Seylers Z Physiol Chem; 1982 Jan; 363(1):95-101. PubMed ID: 6277759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homogeneous [mono-125I-Tyr10]- and [mono-125I-Tyr13] glucagon.
    Pingoud V
    J Chromatogr; 1985 Aug; 331(1):125-32. PubMed ID: 4044734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assay for the glucagon receptor.
    Rojas FJ; Birnbaumer L
    Methods Enzymol; 1985; 109():3-12. PubMed ID: 2985919
    [No Abstract]   [Full Text] [Related]  

  • 12. Photoaffinity labeling of the glucagon receptor with a new glucagon analog.
    Wright DE; Horuk R; Rodbell M
    Eur J Biochem; 1984 May; 141(1):63-7. PubMed ID: 6327311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase.
    Hoosein NM; Gurd RS
    FEBS Lett; 1984 Dec; 178(1):83-6. PubMed ID: 6094259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of radioiodinated photoactivable glucagon by isocratic high-performance liquid chromatography.
    Sonnenberg J; Pingoud V
    J Chromatogr; 1985 Aug; 331(1):133-9. PubMed ID: 4044735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential acid stabilities of citraconylated amino groups of glucagon. Preparation of N alpha-citraconyl glucagon and evaluation of its biological properties.
    Liepnieks JJ; Epand RM
    Biochim Biophys Acta; 1982 Oct; 707(2):171-7. PubMed ID: 6291617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthetic peptide antagonists of glucagon.
    Unson CG; Andreu D; Gurzenda EM; Merrifield RB
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4083-7. PubMed ID: 3035568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of glucagon receptors in rat brain.
    Hoosein NM; Gurd RS
    Proc Natl Acad Sci U S A; 1984 Jul; 81(14):4368-72. PubMed ID: 6087321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon antagonists. Synthesis and inhibitory properties of Asp3-containing glucagon analogs.
    Andreu D; Merrifield RB
    Eur J Biochem; 1987 May; 164(3):585-90. PubMed ID: 3032623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
    Frandsen EK; Thim L; Moody AJ; Markussen J
    J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [mono[125I]iodo-Tyr10,MetO17]-vasoactive intestinal polypeptide. Preparation, characterization, and use for radioimmunoassay and receptor binding.
    Martin JL; Rose K; Hughes GJ; Magistretti PJ
    J Biol Chem; 1986 Apr; 261(12):5320-7. PubMed ID: 3007497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.